Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
June 9, 2016
Effect of Transplant on Platelet Function Markers (P-Selectin and Platelet Aggregation) and Adiponectin in Renal Transplant Patients
Garip Sahin, Gökhan Temiz, Sultan Ozkurt, et al.
Cytogenetic and Genome Research
|
December 16, 2021
An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3
Sevgi Isik, Gulcin Gunden, Eren Gunduz, et al.
Current Cancer Drug Targets
|
September 6, 2018
c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression
Merve Aksoz, Esra Albayrak, Galip Servet Aslan, et al.
European Journal of Haematology
|
October 15, 2010
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group
Meral Beksac, Rauf Haznedar, Tulin Firatli-Tuglular, et al.
Scientific Reports
|
May 16, 2020
Development of Small Molecule MEIS Inhibitors that modulate HSC activity
Raife Dilek Turan, Esra Albayrak, Merve Uslu, et al.
Journal of Hematology & Oncology
|
March 19, 2023
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Jia Chen, et al.
Molecular Cytogenetics
|
January 7, 2021
Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
Beyhan Durak Aras, Sevgi Isik, Hava Uskudar Teke, et al.
Blood
|
May 2, 2023
Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170
Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, et al.
Bone Marrow Transplantation
|
June 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT
Sarah Kayser, Arnon Nagler, Allain Thibeault Ferhat, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 3, 2020
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma
Meral Beksac, Yildiz Aydin, Hakan Goker, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
June 9, 2016
Effect of Transplant on Platelet Function Markers (P-Selectin and Platelet Aggregation) and Adiponectin in Renal Transplant Patients
Garip Sahin, Gökhan Temiz, Sultan Ozkurt, et al.
Cytogenetic and Genome Research
|
December 16, 2021
An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3
Sevgi Isik, Gulcin Gunden, Eren Gunduz, et al.
Current Cancer Drug Targets
|
September 6, 2018
c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression
Merve Aksoz, Esra Albayrak, Galip Servet Aslan, et al.
European Journal of Haematology
|
October 15, 2010
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group
Meral Beksac, Rauf Haznedar, Tulin Firatli-Tuglular, et al.
Scientific Reports
|
May 16, 2020
Development of Small Molecule MEIS Inhibitors that modulate HSC activity
Raife Dilek Turan, Esra Albayrak, Merve Uslu, et al.
Journal of Hematology & Oncology
|
March 19, 2023
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Jia Chen, et al.
Molecular Cytogenetics
|
January 7, 2021
Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
Beyhan Durak Aras, Sevgi Isik, Hava Uskudar Teke, et al.
Blood
|
May 2, 2023
Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170
Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, et al.
Bone Marrow Transplantation
|
June 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT
Sarah Kayser, Arnon Nagler, Allain Thibeault Ferhat, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 3, 2020
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma
Meral Beksac, Yildiz Aydin, Hakan Goker, et al.
Page
of 6